Axogen (AXGN) Operating Income Growth (3y) (2013 - 2026)
Axogen (AXGN) Operating Income Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.54 Bn | 176.25 Bn | 6.27 Bn | -3.76% |
| 2 | Stryker | 128.93 Bn | 126.05 Bn | 3.81 Bn | 8.39% |
| 3 | Medtronic | 108.84 Bn | 99.62 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 68.42 Bn | 66.96 Bn | 3.61 Bn | 25.88% |
| 5 | Edwards Lifesciences | 47.32 Bn | 43.65 Bn | 1.29 Bn | 7.13% |
| 6 | GE HealthCare Technologies | 28.46 Bn | 26.18 Bn | 1.98 Bn | -2.70% |
| 7 | Dexcom | 28.46 Bn | 27.34 Bn | 750.30 Mn | 75.54% |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.42 Bn | 2.07 Bn | 34.83% |
| 10 | Axogen | 2.09 Bn | 1.99 Bn | 46.19 Mn | 27.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.20% |
| Dec 31, 2025 | -20.33% |
| Sep 30, 2025 | 33.77% |
| Jun 30, 2025 | 30.28% |
| Mar 31, 2025 | 47.26% |
| Dec 31, 2024 | 33.45% |
| Sep 30, 2024 | 63.85% |
| Jun 30, 2024 | 60.89% |
| Mar 31, 2024 | 9.83% |
| Dec 31, 2023 | 15.92% |
| Sep 30, 2023 | -56.75% |
| Jun 30, 2023 | 5.79% |
| Mar 31, 2023 | 4.80% |
| Dec 31, 2022 | 8.91% |
| Sep 30, 2022 | 7.39% |
| Jun 30, 2022 | -1.08% |
| Mar 31, 2022 | -3.52% |
| Dec 31, 2021 | 2.94% |
| Sep 30, 2021 | -11.43% |
| Jun 30, 2021 | -14.08% |